Investors.ascendispharma.com

  1. Home
  2. Investors.ascendispharma.com

Significant Health and Quality of Life Improvements Achieved in

WEBTransCon CNP is the first investigational product to demonstrate improvements in health-related quality of life and disease impacts in children with …

Actived: 9 days ago

URL: https://investors.ascendispharma.com/news-releases/news-release-details/significant-health-and-quality-life-improvements-achieved

Investors & News Ascendis Pharma

WEBAscendis Pharma is applying our innovative TransCon™ technologies to build a leading, fully integrated biopharmaceutical company focused on making a meaningful difference …

Category:  Health Go Health

investors.ascendispharma.com

WEBTable of Contents. Filed Pursuant to Rule 424(b)(5) Registration No. 333-216882 . PROSPECTUS SUPPLEMENT (To Prospectus dated April 5, 2017) Up to $100,000,000 …

Category:  Health Go Health

New Company Eyconis Formed to Develop Ascendis Pharma …

WEBCOPENHAGEN, Denmark, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced the formation and launch with Frazier Life Sciences …

Category:  Health Go Health

Ascendis Pharma A/S Reports Full Year 2021 Financial Results and

WEBA live webcast of the conference call will be accessible from the Investors and News section of the Ascendis Pharma website at www.ascendispharma.com.A replay of …

Category:  Health Go Health

Ascendis Pharma A/S Announces Presentations for TransCon™ …

WEBCOPENHAGEN, Denmark, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon …

Category:  Health Go Health

Ascendis Pharma A/S Announces U.S. Food and Drug …

WEBA live webcast of the conference call will be available on the Investors and News section of the Ascendis Pharma website at www.ascendispharma.com.A webcast …

Category:  Health Go Health

Ascendis Pharma A/S Announces New “Outgrow GHD” …

WEBCOPENHAGEN, Denmark, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon …

Category:  Health Go Health

Ascendis Pharma A/S Receives European Approval for TransCon™ …

WEBTransCon hGH (approved by the European Commission as Lonapegsomatropin Ascendis Pharma) is a once-weekly prodrug of somatropin for …

Category:  Health Go Health

Ascendis Pharma A/S Announces Target Enrollment Achieved in …

WEB– Ascendis expects to complete enrollment of subjects still in screening within one week – – PaTHway top-line data now anticipated in Q1 2022 and submission of a …

Category:  Health Go Health

Ascendis Pharma Reports Full Year 2022 Results

WEBNet finance income was €1.7 million in 2022 compared to a net finance income of €55.8 million in 2021. For the full year 2022, Ascendis Pharma reported a net …

Category:  Health Go Health

Ascendis Pharma Announces European Commission Approval of …

WEB- YORVIPATH (developed as TransCon PTH) is a parathyroid hormone (PTH) replacement therapy indicated for the treatment of adults with chronic …

Category:  Health Go Health

One-Year Data from Phase 3 Trial of TransCon™ PTH in Adults with

WEB- Oral presentation of results showed sustained improvements through Week 52, as well as safety and tolerability similar to that previously reported for the initial 26 …

Category:  Health Go Health

Ascendis Pharma A/S Will Appoint Jesper Høiland as Global Chief

WEBCOPENHAGEN, Denmark, May 11, 2020 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ …

Category:  Health Go Health

Ascendis Pharma Introduces Vision 2030 Ascendis Pharma

WEBthe Company’s engine for future innovation. COPENHAGEN, Denmark, Jan. 07, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today …

Category:  Health Go Health

News Releases Ascendis Pharma

WEBJanuary 29, 2024. New Company Eyconis Formed to Develop Ascendis Pharma Ophthalmology Assets with $150 Million Commitment from External Investors.

Category:  Health Go Health

5th Annual Evercore ISI HealthCONx Conference Ascendis Pharma

WEBAscendis, Ascendis Pharma, Ascendis Pharma logo, the company logo and TransCon are trademarks owned by the Ascendis Pharma group

Category:  Health Go Health

Ascendis Pharma Presents Results from Long-Term enliGHten Trial …

WEB- The majority of children and adolescents treated once weekly with TransCon hGH (lonapegsomatropin) met or exceeded average parental height SDS at …

Category:  Health Go Health

News Releases Ascendis Pharma

WEBJanuary 31, 2024. Ascendis Pharma to Report Full Year 2023 Financial Results and Provide Business Update on February 7, 2024. January 31, 2024. Ascendis Pharma …

Category:  Health Go Health

SEC Filing Ascendis Pharma

WEBUNITED STATES . SECURITIES AND EXCHANGE COMMISSION . Washington, D.C. 20549 . FORM 6-K. REPORT OF FOREIGN PRIVATE ISSUER . PURSUANT TO …

Category:  Health Go Health

TransCon™ PTH Top-Line Phase 3 Data from PaTHway

WEBTransCon PTH PaTHway Trial Top-Line Data at Week 26. PaTHway Trial met primary and all key secondary endpoints. 78.7% of patients (48 of 61) treated with TransCon PTH …

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Fayette county tennessee health department

 › Personal care for mental health professionals

 › Old greenbelt family health fax

 › Old greenbelt family health md

 › Healthy naturals whey protein powder

 › Kff health insurance calculator 2021

 › Health care managerial resume sample

 › Mental health nurse practitioner handbook pdf

 › Healthcare indigenous cultural safety

 › What is a mental health practitioner

Recently Searched

 › Healthscopebenefits.com member login

 › Healthy paws contact number

 › Health services llc idaho

 › Shadow health endocrine system intervention

 › Greenbelt family health nepean

 › Nys of health sign in

 › Manitoba provincial health care plan

 › Mental health services in canada 2022

 › Mississippi department of health office

 › Air pollution health statistics